Development, Clinical Validation and Manufacturing Scale up of FIbroFix Meniscus: A mechanically advanced, tissue regenerative, meniscal cartilage repair implant

A torn meniscus can now be repaired with an implant made from silk protein that mimics natural cartilage and encourages new tissue to grow. This matters because meniscal cartilage injuries are common, especially in active adults, and current treatments often fail to restore full function. Without effective repair, the knee joint deteriorates, leading to osteoarthritis—a painful, irreversible condition that limits mobility and often requires joint replacement surgery. The FibroFix implant addresses this gap by combining mechanical strength with biological regeneration, offering a treatment for both small tears and larger, more severe injuries where osteoarthritis is almost certain to develop. If this research succeeds, the implant could become a standard surgical option for meniscal repair, reducing the need for partial knee replacements and delaying or preventing the onset of osteoarthritis. That would directly improve quality of life for patients—restoring mobility, reducing pain, and keeping people active longer. On a larger scale, it could lower the burden on orthopaedic services and reduce the number of knee replacements performed each year, with significant implications for healthcare costs and surgical waiting lists.